Trial intelligence / Profile preview

Bioavailability, pharmacokinetics and pharmacodynamics of insulin aspart via CSII (basal rate resolution)

2007-001912-21Phase 4Completed

Sponsor
Aarhus University Hospital
Start
May 2007
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, single-arm trial of insulin aspart in diabetes mellitus type 1 (T1D), sponsored by Aarhus University Hospital. Primary endpoints: Bioavailability of insulin aspart via CSII, Pharmacokinetics of insulin aspart via CSII and 1 more. Started May 2007; status: completed.

02

Drugs

insulin aspart
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on 2007-001912-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-001912-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call